Taofeek K. Owonikoko

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• A phase 1 study of berzosertib (M6620, VX‐970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)

  Cancer · 2026-03-13

• Impact of a Precision Medicine Navigator on Genomic Test Utilization in Black Patients With Prostate Cancer

  JCO Oncology Practice · 2026-03-03

• Multiomic characterization of small cell lung cancer: Real‐world insights into therapeutic opportunities

  Cancer · 2026-02-28

• Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005

  Journal of Clinical Oncology · 2026-01-13 · 9 citations

• Brief Report: Multi-Institution Real-World Analysis Evaluating Safety, Efficacy, and ctDNA Dynamics After Tarlatamab in Patients With Previously Treated SCLC and LCNEC

  JTO Clinical and Research Reports · 2025-11-21 · 2 citations

• IDeate-Lung02: a Phase 3 study of second-line ifinatamab deruxtecan in patients with relapsed small cell lung cancer

  Future Oncology · 2025-10-07 · 5 citations

• Phase I study of palbociclib with cisplatin or carboplatin in the management of patients with advanced pancreatic cancer

  The Oncologist · 2025-09-17 · 1 citations

• Data from Multidimensional Analysis of B7 Homolog 3 RNA Expression in Small Cell Lung Cancer Molecular Subtypes

  2025-08-14

• International Medical Graduates Representation at International Oncology Conference Meetings: An Analysis of ASCO Annual Meetings

  JCO Oncology Practice · 2025-06-27 · 1 citations

• Multidimensional Analysis of B7 Homolog 3 RNA Expression in Small Cell Lung Cancer Molecular Subtypes

  Clinical Cancer Research · 2025-06-24 · 7 citations

• Tarlatamab versus chemotherapy (CTx) as second-line (2L) treatment for small cell lung cancer (SCLC): Primary analysis of Ph3 DeLLphi-304.

  Journal of Clinical Oncology · 2025-06-04 · 9 citations

• Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

  New England Journal of Medicine · 2025-06-02 · 183 citations

• Recognizing international medical graduates: Awards and committee membership in ASCO.

  Journal of Clinical Oncology · 2025-05-28

• International medical graduates (IMGs) in leadership roles within academic oncology in the United States (US).

  Journal of Clinical Oncology · 2025-05-28 · 1 citations

• Career transitions and practice patterns among international medical graduates in oncology workforce: A US nationwide analysis.

  Journal of Clinical Oncology · 2025-05-28

• Research productivity of international medical graduate (IMG) hematology and oncology fellows in the United States (US).

  Journal of Clinical Oncology · 2025-05-28

• Correction: EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repair

  Oncogene · 2025-03-17

• Uncovering the rewired IAP-JAK regulatory axis as an immune-dependent vulnerability of LKB1-mutant lung cancer

  Nature Communications · 2025-03-08 · 6 citations

• Updated phase 1 data for the DLL3/CD3 IgG-like T-cell engager BI 764532 in DLL3-positive tumors: focus on extrapulmonary neuroendocrine carcinomas

  Endocrine Abstracts · 2025-03-06

• Practical management of adverse events in patients receiving tarlatamab, a delta‐like ligand 3–targeted bispecific T‐cell engager immunotherapy, for previously treated small cell lung cancer

  Cancer · 2025-01-28 · 34 citations